Benjamin A. Smith

Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model

Lauren A. Laboissonniere, R. Nitsch, J. Rothstein, 2019, Neuron.

Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β

P. Weinreb, T. Walz, K. P. Kilambi, 2018, Scientific Reports.

MOG autoantibodies trigger a tightly-controlled FcR and BTK-driven microglia proliferative response.

John C. Silbereis, R. Ransohoff, M. Mingueneau, 2021, Brain : a journal of neurology.

A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport

Paul Vulto, S. J. Trietsch, Remko van Vught, 2018, Fluids and Barriers of the CNS.

Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models

R. Nitsch, P. Auluck, P. Weinreb, 2019, Neurobiology of Disease.

Characterization of tau binding by gosuranemab

J. Trojanowski, V. Lee, Richelle Sopko, 2020, Neurobiology of Disease.

Functional activity of anti-LINGO-1 antibody opicinumab requires target engagement at a secondary binding site

Richelle Sopko, S. Mi, X. Lee, 2020, mAbs.